The Crafoord Prize in Polyarthritis 2025, worth 6 million Swedish kronor, is awarded to Christopher Goodnow, Australia, and David Nemazee, USA. They discovered important mechanisms that prevent B ...

According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...

The controversial biohacker has detailed his latest experiment in age reversal using full plasma replacement therapy.

Celltrion, a leading Korean biotechnology firm, has successfully developed Zymfentra, a subcutaneous version of the company’s ...

Intranasal foralumab can modulate a number of immune cell types in people with non-active SPMS, developer Tiziana Life ...

Roche Holding AG said profit will probably outpace sales growth this year as the Swiss drugmaker works to keep research costs in check and looks for deals to build its pipeline of experimental ...

As reports of rising Guillain–Barré syndrome cases in Maharashtra come in, a neurologist shares a simple guide on what you need to know about this autoimmune condition ...

Group sales grew by 7%1 at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics.Excluding COVID-19, Group sales increased by 9%.

The FDA clears ALLO's investigational new drug application to start clinical studies on its investigational CAR T product, ALLO-329, for autoimmune diseases.

The company expects sales and core earnings to keep growing this year after beating analysts’ expectations for 2024, and the ...

Teva Pharmaceutical Industries Limited’s TEVA share price has dipped by 13.89%, which has investors questioning if this is ...

Data from the largest patient-reported real-world data exploration underlines new opportunities for medical research to ...